# Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

Study · id `cardio:ct-nct07349875` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07349875](<https://clinicaltrials.gov/study/NCT07349875>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07349875

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3826 participants.

## Technical summary

Registry record NCT07349875. Randomized; single masking; primary purpose treatment. Start 2026-01-01 (actual); primary completion 2029-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3826 participants (planned count; ClinicalTrials.gov record NCT07349875, source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)
- Started: 2026-01-01 (actual) (ClinicalTrials.gov record NCT07349875, source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)
- Primary completion: 2029-12-30 (anticipated) (ClinicalTrials.gov record NCT07349875, source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)
- Completion: 2030-06-30 (anticipated) (ClinicalTrials.gov record NCT07349875, source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07349875, source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07349875-2026-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
- Acronym: COLOR
- Condition: Coronary Artery Disease (CAD)
- Intervention (Drug): Colchicine combined with Guideline-Directed Medical Therapy
- Lead sponsor: Nanjing First Hospital, Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Nanjing First Hospital, Nanjing Medical University (`cardio:org-nanjing-first-hospital-nanjing-medical-university`)

## Provenance

Content hash: 465fd306cb4b48bee339903f833cbd13ff189917a606f72e33ea04ff83f38193
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
